A chronic state of impaired venous drainage from the central nervous system,
4
Recently, the topic of chronic cerebrospinal venous insufficiency (CCSVI) and its potential relationship to multiple sclerosis (MS) has generated tremendous interest in the news media, spilling over to the patient and scientific communities.
Described as a state of chronic impaired venous drainage from the central nervous system (CNS), the emergence of CCSVI with respect to MS is based on the work done by Zamboni and colleagues (1). This was followed by a small open-label study conducted to study the effect of endovascular angioplasty in MS patients with CCSVI (2) . Prompted by these series of events, this "Point of View" will review available information on CCSVI, its potential relationship to MS pathology, and what further research needs to be undertaken while keeping patient safety foremost. were not seen in normal subjects, although others have reported internal jugular vein valve insufficiency in 29 to 38% of healthy volunteers under pressurecontrolled maneuvers (4, 5) . In the study by Zamboni and colleagues (1), the presence of at least two of these anomalous parameters in a single subject was defined as abnormal. They reported that only MS patients and not controls met the criteria for abnormal extracranial cerebral venous outflow. This observation perfectly overlapped with the diagnosis of MS, with a reported 100% sensitivity, 100% specificity, 100% positive predictive value, and 100% negative predictive value. highly unusual findings in clinical research. With such high level of diagnostic accuracy, These findings could reflect spectrum bias, which occurs when a diagnostic test is assessed under sampling conditions that are not unlikely to be clinically representative (6) . Moreover, these findings are not easy to interpret because it is difficult to determine flow in the deep cerebral veins using ultrasound since the angle of insonation is greater than 60 degrees. There is also the potential of interference arising from the pulsation signal of the posterior communicating artery located adjacent to the draining jugular sinuses.
In a separate study, 65 MS patients and 235 controls underwent TCCS-ECD (1).
While the technician and the interpreting physician were blinded to the diagnosis, it is not clear if the performing sonographer was blinded to the diagnosis. The authors claim report that they were able to separate 100% of MS patients from controls. also a difficult result to achieve. All 65 MS patients, as part of a non-6 blinded sub-study, underwent selective catheterization of the IJV and azygous veins (AV) (1). They found that IJV and AV were stenosed in 91% and 86% of the patients, respectively. More recently, percutaneous transluminal angioplasty (PTA) was performed in these 65 MS patients, who were then followed for up to 18 months (2) . During this period, it was determined that some of the clinical outcomes were improved, mostly in the relapsing-remitting MS cohort (35/65).
However, the small sample size, lack of controls, unblinded neurologic evaluations, significant re-stenoses of 47% IJV, and inconsistent MRI protocols limit the interpretation of their data. Due to high re-stenosis rate, they suggested that a "logical alternative would be stent insertion" (2) . Furthermore, all patients remained on their disease modifying therapies, making any interpretation of "efficacy" even more tenuous. In a separate publication, the same investigators imply that CCSVI causes venous reflux leading to iron build up in the brain, which may be a primary event in the MS disease pathology, triggering subsequent inflammatory injury to the CNS (7). The potential role of increased iron deposition in the brain and iron-mediated injury to the CNS is not exclusive to MS and is well-documented in many neurological disorders, particularly neurodegenerative diseases this phenomenon is not exclusive to MS (8, 9 ). Yet, CCSVI was never observed in the "other neurologic disease" controls studied by Zamboni and colleagues that included Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (1).
As a result of the great deal of media attention that has been given to CCSVI, the Interestingly, most other systemic autoimmune diseases also show greater prevalence in women than men, although, stagnant venous outflow may not be germane to the known pathology of those diseases such as lupus and rheumatoid arthritis (13) . Since the peak age of incidence of MS is between 25 and 35 years (14) , it is unclear why it would take two to three decades for a Being a "vascular" phenomenon, it would be logical to expect a chronically stagnant venous flow from the CNS, only to get worse and more prevalent over time. Yet the incidence of MS becomes rare at age 50 years and older (14) .
Similarly, MS is rare in the tropics and subtropics (16) The pathology of MS, characterized by the hallmark of inflammatory demyelination, is different from that seen in conditions of Venous occlusion secondary to flow disturbances The latter is characterized by hemorrhagic and ischemic infarctions, and edema associated with increased intracranial pressure (26) . These features are not typically seen in the brain or spinal cord of MS patients. Furthermore, the widespread primary demyelination, characteristic for both white and grey matter lesions in MS patients (27) is not present in 
